Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Avalo Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −16 vs. Q3 2023
- Shares held
- 23.0K
- −1.32M (−98.3%) vs. Q3 2023
- Total value
- $209.4K
- +$50.4K (+31.7%) vs. Q3 2023
- New holders
- 3
- 0 more added
- Sold out
- 19
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 15,876 | $144.5K | 0.00% | −88,814−84.8% | Reduced |
| Natixis | 4,604 | $43.3K | 0.00% | +4,604 | New |
| Tower Research Capital LLC (TRC) | 1,766 | $16.1K | 0.00% | −47,970−96.4% | Reduced |
| FNY Investment Advisers, LLC | 522 | $4.00K | 0.00% | +522 | New |
| Royal Bank of Canada | 138 | $1.00K | 0.00% | −333−70.7% | Reduced |
| Morgan Stanley | 44 | $400 | 0.00% | −10,470−99.6% | Reduced |
| Wells Fargo & Company | 8 | $73 | 0.00% | −1,233−99.4% | Reduced |
| Group One Trading, L.P. | 2 | $18 | 0.00% | −172−98.9% | Reduced |
| UBS Group AG | 2 | $18 | 0.00% | −110−98.2% | Reduced |
| JPMorgan Chase & Co | 2 | $18 | 0.00% | +2 | New |
| Advisor Group Holdings, Inc. | 1 | $9 | 0.00% | −346−99.7% | Reduced |
| First Horizon Advisors, Inc. | 1 | $9 | 0.00% | −275−99.6% | Reduced |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −283,306−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −185,345−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −184,373−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −133,518−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −91,817−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −81,000−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −37,358−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −36,153−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,482−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −25,643−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,714−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −18,582−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,498−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,601−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −10,836−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −279−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |